World Congress on Lung Cancer

orange__line
Back to NEWS

As part of MedSIR‘s goal of expanding its horizons, MedSIR will also be present at the 17th World Congress on Lung Cancer in Vienna. MedSIR is currently involved in two Lung Cancer trials as well as a collaboration with Ariad Pharmaceuticals regarding its Phase 3 ALTA-1L pivotal trial.

iaslc-newswww.iaslc.org


Share (and comment) this content

Back to NEWS

Botón CONTACT US